GAMA
BIIB icon

Graticule Asia Macro Advisors’s Biogen BIIB Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-41,000
Closed -$10.7M – 58
2016
Q1 		$10.7M Buy
+41,000
New +$10.8M 0.84% 31

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Graticule Asia Macro Advisors's BIIB Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Biogen (BIIB) in Q4 2018, closing a stake of 800 shares — an estimated $283K sold.

Graticule Asia Macro Advisors first reported a position in BIIB in Q3 2015 and held it in 6 quarters. The position peaked at $8.77M in Q3 2016. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Graticule Asia Macro Advisors reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 800 Biogen shares in Q4 2018, an estimated $283K.
  • Graticule Asia Macro Advisors first reported a position in Biogen in Q3 2015 and held it in 6 quarters.
  • Graticule Asia Macro Advisors's Biogen position peaked at $8.77M in Q3 2016.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.